AGL 38.41 Decreased By ▼ -0.07 (-0.18%)
AIRLINK 197.10 Decreased By ▼ -5.92 (-2.92%)
BOP 9.81 Decreased By ▼ -0.36 (-3.54%)
CNERGY 6.34 Decreased By ▼ -0.20 (-3.06%)
DCL 9.26 Decreased By ▼ -0.32 (-3.34%)
DFML 38.20 Decreased By ▼ -1.82 (-4.55%)
DGKC 96.00 Decreased By ▼ -2.08 (-2.12%)
FCCL 35.00 Increased By ▲ 0.04 (0.11%)
FFBL 84.50 Decreased By ▼ -1.93 (-2.23%)
FFL 13.60 Decreased By ▼ -0.30 (-2.16%)
HUBC 125.51 Decreased By ▼ -6.06 (-4.61%)
HUMNL 13.85 Decreased By ▼ -0.17 (-1.21%)
KEL 5.21 Decreased By ▼ -0.40 (-7.13%)
KOSM 7.30 Increased By ▲ 0.03 (0.41%)
MLCF 44.50 Decreased By ▼ -1.09 (-2.39%)
NBP 60.50 Decreased By ▼ -5.88 (-8.86%)
OGDC 215.01 Decreased By ▼ -5.75 (-2.6%)
PAEL 38.75 Increased By ▲ 0.27 (0.7%)
PIBTL 8.40 Decreased By ▼ -0.51 (-5.72%)
PPL 192.00 Decreased By ▼ -5.88 (-2.97%)
PRL 39.85 Increased By ▲ 0.82 (2.1%)
PTC 25.12 Decreased By ▼ -0.35 (-1.37%)
SEARL 105.75 Increased By ▲ 2.70 (2.62%)
TELE 8.75 Decreased By ▼ -0.27 (-2.99%)
TOMCL 36.06 Decreased By ▼ -0.35 (-0.96%)
TPLP 14.05 Increased By ▲ 0.30 (2.18%)
TREET 24.76 Decreased By ▼ -0.36 (-1.43%)
TRG 56.60 Decreased By ▼ -1.44 (-2.48%)
UNITY 33.35 Decreased By ▼ -0.32 (-0.95%)
WTL 1.61 Decreased By ▼ -0.10 (-5.85%)
BR100 11,721 Decreased By -169.3 (-1.42%)
BR30 36,521 Decreased By -835.8 (-2.24%)
KSE100 108,961 Decreased By -2109.7 (-1.9%)
KSE30 34,209 Decreased By -699.7 (-2%)
Business & Finance

Moderna taps Baxter to support fill and finish of 60-90mn COVID-19 vaccine doses

  • Moderna's two-shot vaccine is one of the three COVID-19 vaccines authorized for emergency use in the United States along with Pfizer/BioNTech and Johnson & Johnson's.
  • Under the pact with Baxter, the fill and finish of Moderna COVID-19 vaccine will take place at the sterile manufacturing facilities located in Bloomington, Indiana, the companies said.
Published March 8, 2021

Drugmaker Baxter International Inc will help fill in vials and package about 60-90 million doses of Moderna Inc's COVID-19 vaccine in 2021, the companies said on Monday.

Moderna's two-shot vaccine is one of the three COVID-19 vaccines authorized for emergency use in the United States along with Pfizer/BioNTech and Johnson & Johnson's .

Moderna, which expects to make 700 million to 1 billion doses of its vaccine this year, said in February that supply to the United States had lagged recently because of "short-term delays" in the final stages of production at its contractor Catalent Inc.

The company had signed a pact with Catalent last year to help support filling and packaging vials with its vaccine.

Under the pact with Baxter, the fill and finish of Moderna COVID-19 vaccine will take place at the sterile manufacturing facilities located in Bloomington, Indiana, the companies said.

Fill and finish is the final step in the manufacturing process of putting the vaccine into vials or syringes, sealing them and packaging them up for shipping.

Baxter has also partnered with Novavax Inc to provide sterile manufacturing services for its COVID-19 vaccine candidate.

Details on other terms of the pact with Moderna were not disclosed.

Comments

Comments are closed.